Trial site
Ophthalmic Consultants of Boston
- 20running trials
- 15closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration23 trials
- Diabetic eye disease5 trials
- Glaucoma1 trial
- Graves' disease1 trial
- High blood pressure1 trial
- Retinitis pigmentosa1 trial
- Phase
- Phase 315 trials
- Phase 212 trials
- Phase 1/22 trials
- Phase 2/32 trials
- Phase 11 trial
- Status
- Completed14 trials
- Active, not recruiting9 trials
- Recruiting7 trials
- Enrolling by invitation3 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- AbbVie5 trials
- Hoffmann-La Roche3 trials
- Kodiak Sciences Inc3 trials
- Astellas Pharma Global Development, Inc.2 trials
- Boehringer Ingelheim2 trials
- and 18 more
Running trials
Recruiting
Enrolling by invitation
Recruiting
Recruiting
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME
Active, not recruiting
Enrolling by invitation
Recruiting
Active, not recruiting
Enrolling by invitation
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration8 recruiting
- Glaucoma1 recruiting
- High blood pressure1 recruiting
Closed trials
Completed
Completed
Manipulating Temporal Expectations to Accelerate Recovery After Cataract Surgery
Completed
Completed
Terminated
Completed
Completed
Completed
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Completed
Completed
Completed
RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)
Completed
Completed
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Completed
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
Site data: ClinicalTrials.govUpdated 17 Nov 2026